JPMorgan reduced SQM's price target to $88 while keeping a neutral rating. This adjustment contrasts with reported strong quarterly earnings and revenue exceeding estimates. Analyst caution signals potential valuation pressure in the mining sector despite operational strength. Market sentiment appears cautious regarding future commodity pricing or demand. SQM retains a Hold consensus with an average target below the new JPM estimate. Strong financials may support stability, though institutional positioning remains moderate at 12.41%.
56 articles
JPMorgan analysts reduced Sociedad Quimica y Minera's price target to $88.00 while maintaining a neutral rating. The company reported strong quarterly earnings of $2.31 per share and a 136.7% year-ove
Engineers Gate Manager LP sold 148,257 shares of Sociedad Quimica y Minera S.A., reducing its stake. SQM reported strong Q2 earnings with 136.7% revenue growth and declared a special dividend.
Sociedad Química y Minera de Chile S.A. declared a quarterly dividend of USD 0.9328 per share, payable on September 21, 2026. The ex-date and record date are both set for September 8, 2026.
Sociedad Quimica y Minera S.A. (NYSE:SQM) received an average 'Hold' recommendation from fifteen brokerages with a $75.27 price target. The company recently reported better-than-expected quarterly res
Deutsche Bank lowered its price target for Sociedad Quimica Y Minera de Chile S.A. shares from $98 to $94 while maintaining a Buy rating.
SQM reported record H1 2026 net income of $1.02 billion with 103% revenue growth driven by lithium sales, while accruing over $1.6 billion in payments to the Chilean State.
SQM will release its June 2026 earnings on August 18, 2026, with analysts forecasting $2.38 billion revenue and $2.03 EPS. AI tools aim to predict market performance to aid investor trading strategies
Sociedad Quimica y Minera is set to publish a financial update focusing on commodity cash flow and distribution flexibility. Market attention centers on lithium conditions, iodine demand, and balance-
Wall Street Zen downgraded Sociedad Quimica y Minera from strong-buy to buy, while broader consensus remains Hold at $73.58. The company recently reported quarterly EPS of $1.28 on $1.76 billion in re
Scotiabank revised SQM's FY2027 EPS forecast to $7.79 with a $93 target. Analyst consensus remains 'Hold' at $73.58, reflecting mixed views on the lithium miner's outlook.
Sociedad Quimica y Minera de Chile SA (SQM) reported robust financial health with a score of 9.81, driven by a 69.79% revenue increase and 165.20% net profit growth year-over-year. High operating effi
Sociedad Quimica y Minera S.A. received a consensus 'Hold' rating from fifteen brokerages with an average 12-month price target of $74.58. Analyst opinions remain mixed despite the company's $19.68 bi
SQM ranks 50th out of 65 in the Chemicals industry with an institutional confidence score of 3.00. Institutional shareholding fell 1.76% quarter-over-quarter to 32.84%, with ETHSX identified as the la
This report outlines the shareholder structure and institutional holdings of Sociedad Química y Minera de Chile (SQM), detailing major investors and ETF positions over recent quarters.
This article details SQM's quarterly and annual cash flow statements, covering operating, investing, and financing activities alongside key financial metrics like Market Cap and P/E TTM.
The Public Employees Retirement System of Ohio reduced its stake in SQM by 48.3% in Q1, selling nearly 120,000 shares while retaining a $10.4 million position amidst mixed institutional activity.
TradingView displays EBIT financial data for Sociedad Química y Minera de Chile SA Pfd Series B, trading under symbol SQM_B0 on the Santiago Stock Exchange.
Financial data overview for Sociedad Química y Minera de Chile SA Preferred Series B shares on the Santiago Stock Exchange, highlighting pretax income metrics and a closed market status with no trades
This article lists various ETFs investing in Sociedad Quimica y Minera de Chile (SQM), a major lithium and mineral producer. It provides fund details such as assets under management and expense ratios
Wall Street Zen upgraded Sociedad Quimica y Minera (SQM) to a strong-buy rating, diverging from the consensus hold. SQM reported Q1 EPS of $1.28 on $1.76 billion revenue, with shares closing down 1.3%
ARGA Investment Management LP initiated a new $21.3 million position in Sociedad Quimica y Minera S.A., accounting for 0.7% of its portfolio despite mixed quarterly earnings of $1.28 per share.
TradingView displays the price-to-sales forward metric for Sociedad Quimica y Minera de Chile S.A. ADR Series B on the BX Swiss exchange.
Sociedad Quimica y Minera de Chile (SQM) has released financial disclosures and SEC filings spanning 2023 to 2026, detailing operational updates and strategic initiatives in the lithium and iodine sec
Analysts project a 2027 price target of $75.31 for Sociedad Quimica y Minera de Chile (SQM) based on 17 evaluations. The report includes EPS and revenue metrics but clarifies it is not investment advi
A financial metrics page displays placeholder data for Sociedad Quimica y Minera de Chile SA's price-to-sales forward ratio without providing specific values.
Sociedad Química y Minera de Chile SA (SQM) has updated its total assets, with market data indicating closed trading status. Financial information is provided by ICE Data Services and FactSet.
TradingView displays the enterprise value to EBIT forward for Sociedad Quimica y Minera de Chile SA Pfd Series B. Market data indicates no trades occurred at the time of publication.
Sociedad Quimica y Minera de Chile SA reported $652.69 million in free cash flow for Q1 2026, with operating cash flow totaling $1.38 billion. The report details annual and quarterly financial metrics
Sociedad Quimica y Minera de Chile SA displays financial actuals and estimates on the BMFBOVESPA exchange. The tool enables trend visualization and comparison of reported results against analyst expec
TradingView displays financial actuals and analyst estimates for Sociedad Quimica y Minera de Chile S.A. Sponsored ADR Pfd Series B, allowing users to compare reported results with valuation metrics a
ChemBrief